EP1513559A4 - Increased delivery of a nucleic acid constrtuct in vivo by the poly-l-glutamate (plg) system - Google Patents
Increased delivery of a nucleic acid constrtuct in vivo by the poly-l-glutamate (plg) systemInfo
- Publication number
- EP1513559A4 EP1513559A4 EP03741818A EP03741818A EP1513559A4 EP 1513559 A4 EP1513559 A4 EP 1513559A4 EP 03741818 A EP03741818 A EP 03741818A EP 03741818 A EP03741818 A EP 03741818A EP 1513559 A4 EP1513559 A4 EP 1513559A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- constrtuct
- plg
- glutamate
- vivo
- poly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15667002A | 2002-05-28 | 2002-05-28 | |
US156670 | 2002-05-28 | ||
US395709 | 2003-03-24 | ||
US10/395,709 US20040014645A1 (en) | 2002-05-28 | 2003-03-24 | Increased delivery of a nucleic acid construct in vivo by the poly-L-glutamate ("PLG") system |
PCT/US2003/016541 WO2003099341A1 (en) | 2002-05-28 | 2003-05-23 | Increased delivery of a nucleic acid constrtuct in vivo by the poly-l-glutamate (plg) system |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1513559A1 EP1513559A1 (en) | 2005-03-16 |
EP1513559A4 true EP1513559A4 (en) | 2006-01-18 |
Family
ID=29586320
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03741818A Withdrawn EP1513559A4 (en) | 2002-05-28 | 2003-05-23 | Increased delivery of a nucleic acid constrtuct in vivo by the poly-l-glutamate (plg) system |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1513559A4 (en) |
CN (1) | CN1662261A (en) |
AU (1) | AU2003273142A1 (en) |
BR (1) | BR0311539A (en) |
CA (1) | CA2485976A1 (en) |
MX (1) | MXPA04011766A (en) |
WO (1) | WO2003099341A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005089810A1 (en) * | 2004-03-22 | 2005-09-29 | Kansai Technology Licensing Organization Co., Ltd. | Method of inducing bone by transferring human osteogenetic factor gene with the use of electroporation method |
ATE413890T1 (en) * | 2004-07-23 | 2008-11-15 | Advisys Inc | GROWTH HORMONE RELEASING HORMONE ENHANCES THE VACCINE-INDUCED IMMUNE RESPONSE |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001006988A2 (en) * | 1999-07-26 | 2001-02-01 | Baylor College Of Medicine | Super-active porcine growth hormone releasing hormone analog |
WO2001066149A2 (en) * | 2000-03-03 | 2001-09-13 | Valentis, Inc. | Nucleic acid formulations for gene delivery and methods of use |
WO2003049700A2 (en) * | 2001-12-11 | 2003-06-19 | Advisys, Inc. | Growth hormone releasing hormone suplementation for treating chronically ill subjects |
-
2003
- 2003-05-23 WO PCT/US2003/016541 patent/WO2003099341A1/en not_active Application Discontinuation
- 2003-05-23 BR BR0311539-9A patent/BR0311539A/en not_active Application Discontinuation
- 2003-05-23 CA CA002485976A patent/CA2485976A1/en not_active Abandoned
- 2003-05-23 CN CN 03814625 patent/CN1662261A/en active Pending
- 2003-05-23 AU AU2003273142A patent/AU2003273142A1/en not_active Abandoned
- 2003-05-23 EP EP03741818A patent/EP1513559A4/en not_active Withdrawn
- 2003-05-23 MX MXPA04011766A patent/MXPA04011766A/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001006988A2 (en) * | 1999-07-26 | 2001-02-01 | Baylor College Of Medicine | Super-active porcine growth hormone releasing hormone analog |
WO2001066149A2 (en) * | 2000-03-03 | 2001-09-13 | Valentis, Inc. | Nucleic acid formulations for gene delivery and methods of use |
WO2003049700A2 (en) * | 2001-12-11 | 2003-06-19 | Advisys, Inc. | Growth hormone releasing hormone suplementation for treating chronically ill subjects |
Non-Patent Citations (3)
Title |
---|
DRAGHIA-AKLI R ET AL: "ELECTRICAL ENHANCEMENT OF FORMULATED PLASMID DELIVERY IN ANIMALS", TECHNOLOGY IN CANCER RESEARCH AND TREATMENT, ADENINE PRESS, SCHENECTADY, NY, US, vol. 1, no. 5, October 2002 (2002-10-01), pages 365 - 371, XP001182428, ISSN: 1533-0346 * |
FEWELL J G ET AL: "Gene therapy for the treatment of hemophilia B using PINC-formulated plasmid delivered to muscle with electroporation", MOLECULAR THERAPY, ACADEMIC PRESS, SAN DIEGO, CA,, US, vol. 3, no. 4, April 2001 (2001-04-01), pages 574 - 583, XP002965532, ISSN: 1525-0016 * |
See also references of WO03099341A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP1513559A1 (en) | 2005-03-16 |
MXPA04011766A (en) | 2005-03-31 |
WO2003099341A1 (en) | 2003-12-04 |
CA2485976A1 (en) | 2003-12-04 |
CN1662261A (en) | 2005-08-31 |
BR0311539A (en) | 2005-10-25 |
AU2003273142A1 (en) | 2003-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2421689B (en) | Drug delivery system | |
EP1448586A4 (en) | Therapeutic methods for nucleic acid delivery vehicles | |
AU2003290524A8 (en) | Nanoparticle delivery system | |
SI1631255T1 (en) | Drug delivery system | |
EP1379291A4 (en) | Integrated medication delivery system | |
HUP0401438A3 (en) | Drug delivery system | |
PL372323A1 (en) | Implantable drug delivery system | |
PL376169A1 (en) | Drug delivery system | |
EP1540157A4 (en) | Improved fuel delivery system | |
GB0311959D0 (en) | Energy delivery system | |
HK1077523A1 (en) | Proliposomal drug delivery system | |
IL174396A0 (en) | Oral drug delivery system | |
EP1667619A4 (en) | Pharmaceutical delivery system | |
HK1081627A1 (en) | Fuel delivery system | |
GB0106860D0 (en) | Vehicle delivery system | |
GB0103877D0 (en) | Novel Drug Delivery system | |
EP1513559A4 (en) | Increased delivery of a nucleic acid constrtuct in vivo by the poly-l-glutamate (plg) system | |
EP1509612A4 (en) | Transcellular drug delivery system | |
GB0110525D0 (en) | Nucleic acid delivery | |
GB0112585D0 (en) | Nucleic acid delivery | |
AU2003297107A8 (en) | Sacromastigophoric therapeutic agent delivery system | |
GB2406518B (en) | Agent delivery system | |
GB0327409D0 (en) | Delivery system | |
TWI350189B (en) | Implantable drug delivery system | |
GB0115136D0 (en) | Drug delivery system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20041222 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7C 07K 14/60 B Ipc: 7C 12N 15/63 B Ipc: 7A 61K 48/00 A |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20051206 |
|
17Q | First examination report despatched |
Effective date: 20080519 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20101201 |